Novel needle technology paves way for simultaneous tissue sampling and cancer treatment
Wednesday, November 3, 2010 - 09:30
in Health & Medicine
A novel technology promises to reduce the risk of tumor spread and bleeding associated with fine-needle biopsy in suspected cancer. The technology is called Anti-Seeding, and has been clinically tested in breast cancer on a small scale in Sweden during a one year period. The researchers will now move forward with larger studies in other cancers, and are also working to develop the technology to enable treatment of some cancers in parallel with the needle diagnostic procedure.